The World Health Organization (WHO) has approved the first diagnostic test for mpox, previously known as monkeypox. This groundbreaking test aims to assist health workers in detecting the virus more quickly and effectively, which is crucial as cases rise in Africa, where more than 30,000 infections and 800 deaths have been reported.
Understanding Mpox and Its Transmission
Mpox is a viral disease that can be transmitted to humans from infected animals and also spread between people through close physical contact. Infected individuals typically show symptoms such as fever, muscle aches, and large, boil-like skin lesions. Early diagnosis is essential to prevent severe cases and control outbreaks.
The WHO’s approval of this test under emergency use provisions aims to significantly enhance diagnostic capabilities, particularly in areas with high transmission rates. By expediting testing, the WHO hopes that affected countries can implement rapid measures to contain the virus's spread, providing relief to regions facing serious mpox outbreaks, like the Democratic Republic of Congo (DRC).
The test, named the Alinity m MPXV assay, was developed by Abbott Molecular, a U.S.-based company. This diagnostic tool analyzes swabs taken from human lesions to identify mpox DNA. Abbott reports that results can be obtained within 115 minutes, enabling swift diagnosis and timely containment actions. Following the WHO's approval, UN agencies are set to acquire these test kits from Abbott for distribution in affected countries, especially in under-resourced areas.
Yukiko Nakatani, WHO Assistant Director-General, highlighted the importance of making quality medical resources available in underserved regions. “Increasing access to quality-assured medical products is central to our efforts in assisting countries to contain the spread of the virus and protect their people,” Nakatani said.
With recent cases confirmed in Ghana, where authorities reported one confirmed case and 230 suspected cases, WHO and health authorities across Africa are optimistic that this new diagnostic test will help curb the spread of mpox. The approval signifies a vital step forward in addressing the virus throughout the continent.
Second Mpox Case Confirmed in Kerala: Man Returning from UAE Hospitalized in Kochi
First Clade 1b Mpox Updates: India Issues Health Advisory Following New Infection
